We enable animal-free cell-based solutions to supercharge cell growth
Almost everything we consume or apply onto our face and body are animal derived. This causes substantial harm to our environment and is not sustainable.
At Cellivate we provide cell-based solutions to replace the slaughter of animals, using sustainable cell technologies. Our proprietary solutions cost a fraction of what's currently deployed in the market. We are presently working with clients in 3 sectors.
Skincare
Within the skincare and cosmetic space, which is set to soar to a market size of $77.4 billion by 2028, there is an increasing number of skincare and cosmetic companies incorporating cell-derived components in their products. their products. The global market for stem cell-based cosmetics is expected to grow from $1.2 billion in 2021 to $4.8 billion by 2028.
Cellivate is uniquely positioned to meet the demand for these components and has already garnered significant traction in this space.
Cultivated Leather
One of the global missions to create environmentally friendly and sustainable product is leather. Conventional leather market is valued at US$647 million with CAGR 47.5% and projected to reach $1 billion by 2027.
Unlike other types of bio-based leather alternatives, cell-based sustainable leathers are produced invitro from the reconstructed skin of exotic animals
As experts in growing cells, Cellivate is using its platform of products, tools, techniques and technologies to grow cultivated leather.
Cultivated Meat
Cultivated meat or cultured meat is produced using cells acquired from animals biopsy without slaughtering the animal.
Cultivated meat is a sustainable alternative to the current animal husbandry methods. The cultivated meat space is poised to disrupt the US$1.6 trillion meat industry, and will be worth US$1.66 billion by 2031 and $11.13 billion by 2041.
Cellivate is working with cultivated meat companies to help them in the growth and scaling up of cell growth, for making meat.
How we help our clients
Our customers love us because…
we reduce their costs and increase their cell production yield; our products fit into existing workflows with stable and reproducible results
